Indications |
Oral Palliative treatment of prostatic carcinoma Adult: 250 mg tid preferably at least 3 days before gonadorelin analogue treatment. |
Contraindications |
Hypersensitivity, severe hepatic impairment, pregnancy and lactation. |
Warnings / Precautions |
Perform liver function tests before starting treatment and at regular intervals. Treatment is not recommended in patients whose ALT values exceed twice the upper limit of normal. Regular assessment of prostate specific antigen level may help to monitor disease progression. Advise patient against discontinuing drug on their own. Exercise caution in patients with cardiac disease. |
Adverse Reactions |
Hot flushes, loss of libido, impotence, gynaecomastia, nausea, vomiting, diarrhoea, increased appetite, sleep disturbances, skin reactions, anaemias, headache, dizziness, malaise, anxiety, hypertension, gastric and chest pain, oedema, blurred vision, hepatitis, jaundice, rash, thirst, pruritus, SLE-like syndrome, drowsiness, confusion, depression, nervousness. |
Drug Interactions |
Increased prothrombin time in patients on long-term warfarin treatment. See Below for More flutamide Drug Interactions |
Mechanism of Actions |
Flutamide is a nonsteroidal 'pure' antiandrogen which acts directly on the target tissues either by blocking androgen uptake or by inhibiting cytoplasmic and nuclear binding of androgen. Distribution: Protein-binding: 90% Metabolism: Rapid and extensive; converted to hydroxyflutamide. Excretion: Urine, faeces (small amounts); 2 hrs (elimination half-life, metabolite). |
Storage Conditions |
Oral: Store at 25°C. |
ATC Classification |
L02BB01 - flutamide ; Belongs to the class of anti-androgens. |
Storage |
Oral: Store at 25°C. |
Available As |
|
Flutamide
Post Review about Flutamide Click here to cancel reply.
Flutamide Containing Brands
Flutamide is used in following diseases
Drug - Drug Interactions of Flutamide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.